In the last trading session, 1.29 million Acadia Healthcare Company Inc (NASDAQ:ACHC) shares changed hands as the company’s beta touched 1.15. With the company’s per share price at $29.14 changed hands at -$0.29 or -0.99% during last session, the market valuation stood at $2.71B. ACHC’s last price was a discount, traded about -182.77% off its 52-week high of $82.40. The share price had its 52-week low at $27.61, which suggests the last value was 5.25% up since then. When we look at Acadia Healthcare Company Inc’s average trading volume, we note the 10-day average is 2.05 million shares, with the 3-month average coming to 1.91 million.
Analysts gave the Acadia Healthcare Company Inc (ACHC) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.46. If we narrow down to specifics, the data shows that 1 out of 8 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 1 recommended ACHC as a Hold, 5 felt it is a Buy and 0 rated the stock as Underweight. Acadia Healthcare Company Inc’s EPS for the current quarter is expected to be 0.36.
Acadia Healthcare Company Inc (NASDAQ:ACHC) trade information
Instantly ACHC was in red as seen at the end of in last trading. With action 0.07%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -26.51%, with the 5-day performance at 0.07% in the green. However, in the 30-day time frame, Acadia Healthcare Company Inc (NASDAQ:ACHC) is -29.03% down. Looking at the short shares, we see there were 5.12 million shares sold at short interest cover period of 3.61 days.
The consensus price target for the stock as assigned by Wall Street analysts is 76, meaning bulls need an upside of 61.66% from its current market value. According to analyst projections, ACHC’s forecast low is 43 with 87 as the target high. To hit the forecast high, the stock’s price needs a -198.56% plunge from its current level, while the stock would need to soar -47.56% for it to hit the projected low.
Acadia Healthcare Company Inc (ACHC) estimates and forecasts
Year-over-year growth is forecast to reach 5.83% up from the last financial year.
Consensus estimates given by 11 financial analysts project the company’s revenue in the current quarter to hit an average of 769.87M. 11 analysts are of the opinion that Acadia Healthcare Company Inc’s revenue for the current quarter will be 844.58M. The company’s revenue for the corresponding quarters a year ago was 768.05M and 796.04M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.24%. The estimates for the next quarter sales put growth at 6.10%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 17.49%. The 2025 estimates are for Acadia Healthcare Company Inc earnings to decrease by -18.77%, but the outlook for the next 5-year period is at -1.36% per year.
ACHC Dividends
Acadia Healthcare Company Inc is expected to release its next quarterly earnings report on 2025-Feb-26.
Acadia Healthcare Company Inc (NASDAQ:ACHC)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 2.98% of Acadia Healthcare Company Inc shares while 109.90% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 113.28%. There are 109.90% institutions holding the Acadia Healthcare Company Inc stock share, with WELLINGTON MANAGEMENT GROUP LLP the top institutional holder. As of 2024-06-30, the company held 11.3414% of the shares, roughly 10.39 million ACHC shares worth $701.87 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 9.7108% or 8.9 million shares worth $600.96 million as of 2024-06-30.
Among Mutual Funds, the top two as of Oct 31, 2024 were Vanguard Specialized-Health Care Fund and iShares Core S&P Midcap ETF . With 5.12 shares estimated at $149.34 million under it, the former controlled 5.52% of total outstanding shares. On the other hand, iShares Core S&P Midcap ETF held about 3.26% of the shares, roughly 3.03 shares worth around $88.33 million.
